Coverage of advanced analytics and AI as applied across Australian healthcare — what works, what the evidence shows, and how regulatory and market context shapes outcomes.
Across retail pharmacy, hospital networks, pharmaceutical companies, and health insurers — these are the analytical questions where data changes understanding.
Modelling the commercial and access impact of PBS listings, PBAC decisions, and subsidy changes — how analytics illuminates patient access, brand dynamics, and therapeutic category shifts.
How scalable data pipelines and resilient analytics infrastructure are architected in practice — from source ingestion and transformation through to curated data products and quality assurance.
How demand forecasting and inventory intelligence work across pharmacy networks and hospital supply chains — the methods, data sources, and limitations in the Australian context.
Analytics methods for understanding patient segments, prescriber territories, and market penetration — and how these are applied to pricing, portfolio, and access decisions.
Using longitudinal analytics to understand treatment adherence, therapy persistence, and dropout patterns — what the evidence shows and what it means for patient support design.
Applying AI and analytics to uncover treatment patterns, patient outcomes, and real-world utilisation trends — evidence generation methods and their limitations.
Sound analytics coverage starts with the question — its constraints, the evidence required, and the decisions it informs. The AIChemist applies that discipline across all coverage.
Australia's healthcare AI adoption is accelerating — but outcomes depend on fit for purpose, regulatory alignment, and genuine integration with clinical and operational workflows. Coverage here is filtered through that lens.
Australia's Healthcare Pulse covers analytics and AI developments each month — free, evidence-rated, and filtered for Australian relevance.